We are excited to announce that Avail has successfully raised $70 million in its latest funding round, reinforcing its commitment to advancing sustainable innovations within the life sciences sector. The AVAIL Global Network, which comprises the cutting-edge Avail Biomedical Research Institute and the strategic consulting arm Avail Pharma, is dedicated to enhancing the landscape of biomedical research and development. With our facilities compliant with Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), we conduct and support high-quality preclinical studies and collaborations aimed at significant therapeutic breakthroughs. The newly-acquired funds will be pivotal in expanding our capabilities for optimizing and testing pulmonary disease models, conducting cell characterization and secretome analyses, and facilitating innovative tissue engineering practices. Moreover, these resources will bolster our efforts in pharmacokinetic testing, exploratory toxicology, and biomarker discovery, crucial elements in the development of transformative therapeutic solutions. Avail Pharma will leverage this infusion of capital to enhance its strategic counseling services, driving the translation of research breakthroughs into viable market applications that directly benefit patients. This funding not only accelerates our existing projects but also enables us to explore new avenues of research that will positively impact the life sciences industry. We are grateful for the continued support from our investors and remain focused on our mission to deliver innovative health solutions that address pressing medical challenges. Stay tuned for updates as we embark on this exciting journey toward advanced biomedical innovation!
Avail Secures $70 Million Investment to Advance Life Sciences Innovations
Recently funded 路 $70.0MPharmaceuticals
Get the full Avail company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
